ICICI Prudential Pharma Healthcare and Diagnostics (P H D) Fund · Regular · Growth
NAV
₹43.7100
as of 14 Jul 2026
Expense Ratio
1.86%
AUM
₹6,565 Cr
Lumpsum returns (CAGR)
- 1Y
- +8.87%
- 3Y
- +25.24%
- 5Y
- +15.93%
- Since Inception
- +20.24%
SIP returns (XIRR)
- 1Y
- +20.01%
- 3Y
- +18.37%
- 5Y
- +20.67%
- Since Inception
- +21.66%
What history actually did — last 8 years (Jul 2018 – Jul 2026)
A ₹5,000 monthly SIP for the last 8 years (Jul 2018 – Jul 2026)
Real NAV backtest
A ₹5,000 monthly SIP would be worth ₹11,52,163 today — ₹4,80,000 invested, 21.6% XIRR.
₹4,80,000
Invested
₹11,52,163
Value today
21.6%
XIRR (p.a.)
A ₹1,00,000 lumpsum, the last 8 years (Jul 2018 – Jul 2026)
Real NAV backtest
₹1,00,000 invested 8 years ago would be ₹4,41,515 today (20.4% CAGR).
A regular withdrawal plan (SWP)
Real NAV backtest
A ₹10,00,000 corpus withdrawing ₹5,000/month since Jul 2018 would still hold ₹32,62,989.
Fund vs Benchmark (TRI)
Same SIP, benchmark total-return index
The same SIP would be worth ₹11,52,163 in this fund vs ₹8,52,006 in the benchmark — outperformance of ₹3,00,157.
Buying the worst day
Real NAV backtest
₹1,00,000 invested on the worst market day of the last 8 years (Jul 2018 – Jul 2026) (22 Mar 2020) would be ₹4,94,457 today (4.95×).
Historical simulation using actual published NAVs for the stated period. Past performance may or may not be sustained in the future. Not investment advice.
Risk Metrics
Trailing 1 year, annualised0.25
Sharpe Ratio
+0.06
Alpha
0.23
Beta
0.24
Sortino
14.92%
Std Dev
-12.27%
Max Drawdown
Performance Comparison
Sectoral allocation
as of 31 May 2026- Pharmaceuticals & Biotechnology78.74%
- Healthcare Services12.12%
- Retailing5.60%
- Insurance1.38%
- Chemicals & Petrochemicals1.19%
- Healthcare Equipment & Supplies0.80%
Each sector links to the mutual funds most exposed to it.
Thinking about ICICI Prudential Pharma Healthcare and Diagnostics (P H D) Fund · Regular · Growth?
Talk to our AMFI-registered team — free, no pressure. We'll help you see if this fund fits your goals.
Fund Details
Available transactions
Portfolio holdings
portfolio shared with ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund - IDCW Option
- 1Sun Pharmaceutical Industries Ltd.12.09%
- 2Dr. Reddy'S Laboratories Ltd.7.70%
- 3Cipla Ltd.7.45%
- 4Mankind Pharma Ltd.7.03%
- 5Divi'S Laboratories Ltd.6.06%
- 6Biocon Ltd.4.71%
- 7Cohance Lifesciences Ltd.4.37%
- 8Alkem Laboratories Ltd.4.08%
- 9Medplus Health Services Ltd3.86%
- 10Max Healthcare Institute Ltd3.36%
Investment Objective
ICICI Prudential Pharma Healthcare and Diagnostics (P H D) Fund · Regular · Growth invests in stocks from a specific sector or theme, offering concentrated exposure to a particular area of the economy. These funds carry sector-specific risks but can deliver significant returns when the underlying sector performs well.
About This Fund
ICICI Prudential Pharma Healthcare and Diagnostics (P H D) Fund · Regular · Growth is a Sectoral / Thematic mutual fund offered by ICICI Prudential Mutual Fund. The fund has been operational for over 8 years. It manages assets worth ₹6,565 Cr, reflecting investor confidence in the fund's strategy. It benchmarks its performance against BSE Healthcare TRI. The current expense ratio is 1.86%.
Who Should Invest?
- •Investors with a high risk appetite seeking long-term wealth creation
- •Investors with an investment horizon of 5 years or more
- •SIP investors who can benefit from rupee cost averaging during market fluctuations